Clinical Trial Update: A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept [Phase 2]

View source ↗

Summary

A phase 2 rollover trial update assessing long-term safety and efficacy of atacicept in IgA nephropathy, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Atacicept (atacicept)

Snippet

Sponsor: Vera Therapeutics, Inc. | Conditions: IgA Nephropathy (IgAN), Renal and Urinary Disorders | Phase 2 | Status: ENROLLING_BY_INVITATION